Literature DB >> 25006821

Polymorphisms of SP110 are associated with both pulmonary and extra-pulmonary tuberculosis among the Vietnamese.

Gregory J Fox1, Dinh Ngoc Sy2, Nguyen Viet Nhung2, Bing Yu3, Magda K Ellis4, Nguyen Van Hung2, Nguyen Kim Cuong5, Luu Thi Lien6, Guy B Marks7, Bernadette M Saunders8, Warwick J Britton8.   

Abstract

BACKGROUND: Tuberculosis (TB) is an infectious disease that remains a major cause of morbidity and mortality worldwide, yet the reasons why only 10% of people infected with Mycobacterium tuberculosis go on to develop clinical disease are poorly understood. Genetically determined variation in the host immune response is one factor influencing the response to M. tuberculosis. SP110 is an interferon-responsive nuclear body protein with critical roles in cell cycling, apoptosis and immunity to infection. However association studies of the gene with clinical TB in different populations have produced conflicting results.
METHODS: To examine the importance of the SP110 gene in immunity to TB in the Vietnamese we conducted a case-control genetic association study of 24 SP110 variants, in 663 patients with microbiologically proven TB and 566 unaffected control subjects from three tertiary hospitals in northern Vietnam.
RESULTS: Five SNPs within SP110 were associated with all forms of TB, including four SNPs at the C terminus (rs10208770, rs10498244, rs16826860, rs11678451) under a dominant model and one SNP under a recessive model, rs7601176. Two of these SNPs were associated with pulmonary TB (rs10208770 and rs16826860) and one with extra-pulmonary TB (rs10498244).
CONCLUSION: SP110 variants were associated with increased susceptibility to both pulmonary and extra-pulmonary TB in the Vietnamese. Genetic variants in SP110 may influence macrophage signaling responses and apoptosis during M. tuberculosis infection, however further research is required to establish the mechanism by which SP110 influences immunity to tuberculosis infection.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25006821      PMCID: PMC4090157          DOI: 10.1371/journal.pone.0099496

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

Tuberculosis (TB) is an airborne infectious disease that remains a major global health priority [1], with 8.7 million new cases and 1.4 million deaths each year [2]. Although one third of the world's population has been infected with M. tuberculosis, the causative bacterium [3], less than 10% of infected individuals will develop active disease in their lifetimes [4]. The probability that an infected individual develops TB depends upon the capacity of the host cellular immune system to recognize and control the infection [5]. The effectiveness of the immune response is influenced by the interplay between a range of environmental [6] and genetic factors [7]. Genetic variability is an important determinant of the effectiveness of the host immune response to M. tuberculosis. Studies in twins [5], genetic linkage studies, association studies [8] and genome wide association studies [9], [10] have demonstrated that host genetic factors modulate the risk infected individuals will develop TB [7]. However, there is heterogeneity in the pattern of genetic associations with TB in different populations [7]. This heterogeneity between published studies is likely to be explained in part by genetic variation between the populations and gene-environment interactions [5], underlining the importance of undertaking association studies in a range of different settings. The SP110 gene was first implicated in the genetic regulation of the immune response to M. tuberculosis in a study of its murine homolog, the interferon-inducible nuclear protein gene 1 (Ipr1) in hypersusceptible mice [11]. Mice with the disease-causing variant of the gene developed necrotic pulmonary cavities similar to those typical of human pulmonary TB [12]. The gene's effect was to modulate macrophage function, independent of Th1 cytokine-producing T-lymphocytes, or inducible nitrous oxide synthase [13]. Despite the fact that SP110 is interferon inducible, the increased susceptibility of this mouse variant was IFN-γ independent. SP110 protein is considered to affect mycobacterial immunity by influencing cell differentiation, activation and apoptosis [14], although the mechanism for this effect remains incompletely understood. In humans, SP110 variants have been implicated in a number of diseases including hepatic veno-occlusive disease with immunodeficiency (VODI) [15], [16], viral hepatitis infection [17] and TB [18]–[23]. Previous studies of the gene in human TB have found apparently inconsistent results. Two single nucleotide polymorphisms (SNPs) of SP110 (rs3948464 and rs2114592) were found to be associated with TB in populations from West Africa [18], while significant associations were identified in India (rs1427294) [24] and China (rs1135791) [25]. However, studies of the gene in other settings have found no evidence of an association [19]–[23] A recent meta-analyses of five SNPs found no consistent associations with TB [26]. Given the heterogeneity of these results, further studies in Asian populations are needed to clarify the relationship between genetic variation in SP110 and TB. Consequently, this study investigated whether SNPs of SP110 were associated with TB in a Vietnamese population.

Materials and Methods

Ethics statement

Ethics approval was obtained from the Human Research Ethics Committee at the University of Sydney, the Scientific Committee at the National Lung Hospital and the Institutional Review Board of the Ministry of Health, Vietnam. Research participants provided written informed consent.

Subjects

Vietnamese patients with TB were recruited from inpatients at three lung disease hospitals in northern Vietnam between 2009 and 2012. Patients with pulmonary TB were sputum smear positive for acid fast bacilli (AFB) diagnosed using standard criteria [27] (Table S1). Patients with extra-pulmonary tuberculosis were diagnosed using usual standardized clinical criteria, listed in the Table S2. Patients were recruited as cases within seven days of commencing treatment. HIV serology was performed using commercial antigen detection kits (Alere Inc, MA, USA). Cases were excluded if they were HIV positive or had a known history of HIV. One sputum sample from each case with pulmonary disease was cultured using either solid or liquid culture media. Sputum smear was performed using fluorescent microscopy. Subjects with both confirmed pulmonary TB and extra-pulmonary TB were included in the pulmonary TB group. Controls were health care workers and medical students with no history of TB and normal chest radiographs, recruited from the three lung disease hospitals and their affiliated district clinics. Two trained radiologists read the chest radiographs for patients and control subjects independently to exclude active disease in controls. Participants gave three to five milliliters of peripheral blood. Genomic DNA was extracted from peripheral blood leukocytes using Qiagen kits according to manufacturer's instructions (Qiagen Corp, CA).

Selection of SNPs

Tag SNPs were selected across the SP110 gene using HapMap data (http://hapmap.ncbi.nlm.nih.gov/) and the International HapMap Project (http://www.hapmap.org/). Data from HapMap Phase III were obtained from the Han Chinese population (CHB), applying the Tagger algorithm to cover 100% of alleles with a pair-wise r2 linkage disequilibrium cut-off of 0.8 [28]. The software was used to force the inclusion of selected SNPs that had been associated with TB in previously published studies [18], [24], [25]. Selection upon data for the Han Chinese Beijing (HCB) population was based upon their genetic similarity with Vietnam's majority Kinh ethnic group [29].

Genotyping

PCR primers were designed in multiplex reactions for 24 SNPs and were allocated to three separate assays. Primer sequences have been included in the Table S3. Multiplex PCR and primer extension were performed according to standard protocols [30]. Multiplex PCR was undertaken in 5 µL reactions in 384 well plates, using approximately 10 ng of genomic DNA, 0.5 µL of 10X proprietary PCR buffer (Sequenom Corporation, San Diego, CA), 20 nmol MgCl2, 2.5 nmol of each dNTP, 0.5 pmol of the primer mix, 1.0 U Taq DNA polymerase (Roche Applied Science, Germany) in TAE (40 mM Tris, 0.01 mM acetic acid, 1 mM EDTA) and 0.8 µL double distilled water. PCR thermal cycling was performed in a PCR thermocycler, comprising initial denaturation of 2 min, then 45 cycles of denaturation at 94°C for 30 seconds, annealing at 56°C for 30 seconds, and extension at 72°C for 1 minute, then a final extension at 72°C for 1 minute. Unincorporated deoxyribonucleoside triphosphates were dephosphorylated by adding 0.5 U shrimp alkaline phosphatase (SAP) enzyme, 0.17 µL SAP Buffer (10x), and 1.53 µL of PCR grade water to each well. The plates were gently vortexed and centrifuged at 2000 g for 30 seconds before incubating them at 37°C for 40 minutes, and transferring them to an 85°C incubator for 5 minutes to denature the SAP enzyme. Primer extension was performed after adding to reaction 0.2 µL iPLEX termination mix, 0.04 µL iPLEX enzyme (Sequenom Corporation, CA, USA), 4.7 to 14.1 nmol extension primers, 0.2 µL buffer mix (10x) and 0.62 µL double distilled water. The mixture was gently mixed and centrifuged for 30 s at 1000 rpm. Initial denaturation was 30 seconds at 94°C. 40 cycles comprised denaturation at 94°C followed by five looped cycles, each with annealing at 52°C for 5 seconds and then extension at 80°C for 5 seconds. A final extension was performed 72°C for 3 minutes, and the samples were then cooled to 4°C. Then 16 µL of water was added to each well. A pre-treated cationic resin (Sequenom Corporation, San Diego) was subsequently added to each mixture of reaction products to remove salts, and the plates were centrifuged at 3200 g for 5 minutes. SNPs were typed using the Matrix Assisted Laser Desorption/Ionisation Time-Of-Flight (MALDI-TOF) mass spectrometry, and spectral peaks were analyzed with Typerv4.0 software (Sequenom) [30].

Statistical and bioinformatics analyses

Alleles for all tag SNPs were tested for an association with all forms of TB using Fisher's exact test. Adjusted analysis was conducted for SNPs that had p-values below a cut-off of 0.1 in the allelic analysis and were polymorphic. If age and gender were found on univariate analysis to be associated with TB, they were to be incorporated as covariates in multivariate analysis. In the adjusted analysis, both recessive and dominant models of inheritance were applied using multivariate analysis for all TB, pulmonary TB and extra-pulmonary TB. To account for multiple testing, a corrected p-value threshold was determined based upon analysis of the effective number of independent tests performed for all SNPs tested in the first stage analysis, excluding SNPs that were non-polymorphic. Following the methods described by Nyholt [31] and Li and Ji [32], we applied the SNPSpD algorithm to determine the effective number of independent tests: Where Meff is the effective number of variables, Var(λobs) is the ratio of the observed eigenvalue variance, and M is its maximum ratio. Using this method, the effective number of independent marker loci, Meff, was calculated to be 6.4507, defining an experiment-wide significance threshold of 0.007751 for each SNP to achieve an experiment-wide overall alpha level of 0.05. The exact Hardy Weinberg Equilibrium (HWE) statistic was used to test deviation from HWE among controls. The χ2 test was performed to compare allele frequencies between our study population and the Han Chinese (CHB) population, using data from available public databases (http://www.ncbi.nlm.nih.gov/SNP/). Multiple permutation testing was performed to identify haplotype blocks using Haploview (version 4.2) [28]. Linkage Disequilibrium (LD) plots were compiled using Haploview. Statistical analyses were conducted using SAS (v9.2, Cary Corp, NC, USA) [28], [33].

In silico analyses

Multi-point imputation was used to test the associations identified and develop probability distributions of untyped genotypes using SNPTEST version 2 (https://mathgen.stats.ox.ac.uk/genetics_software/snptest/snptest.html). In silico bioinformatic analyses to explore the predicted functional impacts of identified SNPs upon protein function were performed using SeattleSeq Annotation 134 (version 7.0.5, http://snp.gs.washington.edu/SeattleSeqAnnotation134/) and MutationTaster (http://mutationtaster.org) [34]. Grantham scores were calculated, where possible [35], [36]. For alleles found to be significantly associated with TB in our study we planned to perform a meta-analysis if there were published data from at least 5 studies in genetically similar ethnic groups. In the absence of sufficient numbers of studies from comparable populations, we planned to present the estimates of each study without presenting a summary estimate.

Results

A total of 566 control subjects and 663 patients were recruited, including 530 patients with smear positive pulmonary TB and 133 patients with extra-pulmonary TB. The features of the study population are described in Table 1. Patients and controls differed in age and gender (p<0.001), and this was adjusted for in the multivariate analysis.
Table 1

Baseline characteristics of TB patients and controls.

Cases (TB Patients)Controls
Number663566
Mean age, years (SD)44.6 (17.3)30.4 (10.6)
Males (%)485 (73.2%)214 (37.8%)
Vietnamese born (%)100%100%
HIV negative (%)618/638 (97%)1
Pulmonary TB530
Extrapulmonary TB
All forms133-
 Lymph node9-
 Meningeal7-
 Pleural105-
 Abdominal10-
 Other2-

HIV serology results were not available for 25 TB patients included in the study. 19 of these stated they had no past history of HIV and had no features of HIV, and data was missing for one subject. SD: standard deviation.

HIV serology results were not available for 25 TB patients included in the study. 19 of these stated they had no past history of HIV and had no features of HIV, and data was missing for one subject. SD: standard deviation. A total of 24 tag SNPs were selected, including four in the exonic regions and 20 in intronic regions. Schematic representations of the location of tag SNPs on the SP110 gene are shown in Figure 1. Overall, 97.4% of included samples were “called” with moderate to high degree of confidence using standard algorithms with Typer v4.0 (Sequenom Inc, CA, USA) [30].
Figure 1

Human SP110 genomic structure showing the location of tested tag SNPs.

All genotyped SNPs were in Hardy Weinberg Equilibrium. Two of the 24 SNPs were non-polymorphic.

Findings in all forms of tuberculosis

Comparison of allelic frequencies between cases and control subjects are shown in Table 2. The effective significance p-value threshold for the 22 polymorphic alleles tested was calculated to be 0.0078, which was applied to the second stage multivariate analysis. Table 3 shows the results of multivariate analysis, with unadjusted analyses shown in Table S4. After adjusting for age and gender in a multivariate analysis, four of these SNPs were associated with all forms of TB assuming a dominant inheritance model (rs10208770, rs10498244, rs11678451 and rs16826860) and one using a recessive model of inheritance (rs7601176), as shown in Table 3. Unadjusted analyses are shown in Table S4. Odds ratios were unable to be calculated for rs3948464 and rs1427294 using a dominant model, as there was a zero value in at least one cell of the two-by-two table. There were two associated SNPs in linkage disequilibrium block 1 (rs10208770, rs10497224), one in LD block 2 (rs11678451) and one was located in LD block 3 (rs16826860) as shown in Figure 2. Multiple permutation testing using Haploview (n = 10,000 variations) found no haplotype blocks or SNPs that met statistical significance. SNP rs10498244 had the highest permutation p-value (p = 0.0904).
Table 2

Allelic frequencies for all tuberculosis patients.

SNP rs number Alleles (Minor:Major) Minor allele frequency (controls) (%) Major allele frequency (controls) (%) Minor Allele frequency (TB patients) (%) Major allele frequency (TB patients) (%) p value *
rs10208770 GT125(11%)1007(89%)191(14.5%)1129(85.5%)0.013
rs10498244 CT165(14.6%)967(85.4%)247(18.7%)1071(81.3%)0.007
rs1135791 CT191(16.9%)941(83.1%)262(19.8%)1058(80.2%)0.06
rs11678451 CT165(14.6%)967(85.4%)237(18%)1081(82%)0.025
rs16826860 AG342(30.2%)790(69.8%)447(33.9%)871(66.1%)0.051
rs3948464 TC8(0.7%)1124(99.3%)1(0.1%)1317(99.9%)0.015
rs7601176 AG129(11.4%)1003(88.6%)115(8.7%)1203(91.3%)0.03
rs1427294 CT8(0.7%)1124(99.3%)2(0.2%)1316(99.8%)0.052

SNP: Single nucleotide polymorphism. Rs number  =  Reference Single Nucleotide Polymorphism number.

*Unadjusted P-value calculated using Fisher’s exact test. Results presented for SNPs included in adjusted analysis.

Table 3

Association of SNPs with pulmonary TB and extra-pulmonary TB by allelic analysis, by adjusted multivariate analysis.

SNPGroupOR (95% CI) Dominant model# p-valueOR (95% CI) Recessive model# p-value
rs10208770 GG+GT vs TT GG vs GT+TT
PTB 1.65 (1.17–2.34) 0.005 * 3.01 (0.84–10.76)0.090
EPTB1.49 (0.92–2.42)0.1065.33 (1.41–20.14)0.014
Pleural TB1.36 (0.79–2.33)0.266 6.96 (1.82–26.58) 0.005
All TB 1.64 (1.19–2.26) 0.002 * 4 (1.28–12.58)0.017
rs10498244 CC+CT vs TT CC vs CT+TT
PTB1.52 (1.11–2.09)0.0102.44 (0.9–6.65)0.081
EPTB1.42 (0.91–2.21)0.122 4.8 (1.68–13.72) 0.003 *
Pleural TB1.44 (0.89–2.34)0.139 5.49 (1.81–16.68) 0.003
All TB 1.55 (1.16–2.07) 0.005 * 2.96 (1.23–7.09)0.015
rs1135791 CC+CT vs TT CC vs CT+TT
PTB1.36 (1–1.85)0.0531.32 (0.57–3.06)0.522
EPTB1.41 (0.91–2.17)0.1222.33 (0.89–6.11)0.085
Pleural TB1.37 (0.85–2.2)0.1992.57 (0.92–7.18)0.072
All TB1.4 (1.05–1.86)0.0211.61 (0.76–3.37)0.211
rs11678451 CC+CT vs TT CC vs CT+TT
PTB1.4 (1.02–1.93)0.0381.13 (0.45–2.81)0.796
EPTB1.72 (1.11–2.66)0.0141.4 (0.41–4.82)0.594
Pleural TB1.81 (1.13–2.91)0.0141.8 (0.52–6.26)0.354
All TB1.54 (1.15–2.06) 0.004 * 1.16 (0.5–2.69)0.722
rs16826860 AA+AG vs GG AA vs AG+GG
PTB1.5 (1.12–2.02) 0.007 * 2.13 (1.33–3.43) 0.002 *
EPTB1.2 (0.8–1.8)0.3730.79 (0.35–1.76)0.565
Pleural TB1.21 (0.77–1.89)0.4010.74 (0.3–1.84)0.523
All TB1.47 (1.12–1.92) 0.005 * 1.74 (1.12–2.7)0.014
rs3948464 TT+TC vs CC TT vs CT+CC
PTBnana6.17 (0.74–51.69)0.093
EPTBnananana
Pleural TBnananana
All TBnana8.22 (0.99–68.42)0.051
rs7601176 GG+GA vs AA GG vs GA+AA
PTB7.01 (1.09–45.04)0.0401.56 (1.07–2.25)0.019
EPTB0.66 (0.15–2.93)0.5811.65 (0.95–2.86)0.076
Pleural TB0.94 (0.17–5.29)0.9401.67 (0.9–3.11)0.107
All TB2.21 (0.54–9.05)0.2681.64 (1.17–2.31) 0.005 *
rs1427294 TT+TC vs CC TT vs TC+CC
PTBnana3.24 (0.65–16.17)0.152
EPTBnananana
Pleural TBnananana
All TBnana4.32 (0.87–21.36)0.073

Adj  =  Adjusted for age & gender. na  =  Not calculated as zero count in at least one cell of the two by two table. EPTB  =  extrapulmonary TB, All TB =  all forms of TB. Pleural TB is a sub-set of extrapulmonary TB.

*indicates SNPs for which the p-value was below the adjusted effective study-wide level of statistical significance (<0.00775), taking into account the number of effective tests [31].

Figure 2

Linkage Disequilibrium Plot of SNPs of SP110 with associations with tuberculosis.

Pairwise D′ values are written as a percentage in each square. High D′ values are dark, low D′ values are light. SNPs associated with tuberculosis in multivariate analysis shown above the plot.

Linkage Disequilibrium Plot of SNPs of SP110 with associations with tuberculosis.

Pairwise D′ values are written as a percentage in each square. High D′ values are dark, low D′ values are light. SNPs associated with tuberculosis in multivariate analysis shown above the plot. SNP: Single nucleotide polymorphism. Rs number  =  Reference Single Nucleotide Polymorphism number. *Unadjusted P-value calculated using Fisher’s exact test. Results presented for SNPs included in adjusted analysis. Adj  =  Adjusted for age & gender. na  =  Not calculated as zero count in at least one cell of the two by two table. EPTB  =  extrapulmonary TB, All TB =  all forms of TB. Pleural TB is a sub-set of extrapulmonary TB. *indicates SNPs for which the p-value was below the adjusted effective study-wide level of statistical significance (<0.00775), taking into account the number of effective tests [31].

Findings in pulmonary TB

An association was identified between pulmonary TB and two SNPs, rs10208770 (OR 1.65, 95% CI 1.17–2.34, padj = 0.005), rs16826860 (OR 1.50, 95% CI 1.12–2.02, padj = 0.007), applying a dominant mode. Using a recessive model, an association was also shown with pulmonary TB for rs16826860 (OR 2.13, 95% CI 1.33–3.43). Allelic frequencies for pulmonary TB are included in Table S5.

Findings in extra-pulmonary TB

Using recessive models there was a significant association between rs10498244 (OR 4.80, 95% CI 1.68–13.72, p = 0.003) and extrapulmonary TB. Both rs10498244 (OR 5.49, 95% CI 1.81–16.68, p = 0.0027) and rs10208770 (OR 6.96, 95% CI 1.82–26.58, p = 0.0046) were associated with pleural TB. Predicted functional effects of the associated SNPs compiled using SeattleSeq and Mutation Taster are shown in Table 4. Figure 1 shows the tested SNPs and the linkage disequilibrium blocks for SP110. Schematic representations of the location of tag SNPs on the SP110 gene are shown in Figure 1. The Linkage Disequilibrium plot in Figure 2 demonstrates that the associated SNPs lie primarily within three adjacent LD blocks.
Table 4

Summary of SNPs in adjusted analysis for all tuberculosis patients.

rs number Alleles (Minor, major) Minor allele % among controls Major allele % among controls Minor allele % among TB patients Major allele % among TB patients p-value * Potential effect on proteina
rs10208770GT11%89%14.5%85.5%0.013No effect
rs10498244CT14.6%85.4%18.7%81.3%0.007No effect
rs1135791CT16.9%83.1%19.8%80.2%0.06Amino acid change M>T. Splice site changes. Possible downstream effect on bromo domain, Zn finger, SAND domain and nuclear localisation signal.
rs11678451CT14.6%85.4%18%82%0.025No effect
rs16826860AG30.2%69.8%33.9%66.1%0.051No effect
rs3948464TC0.7%99.3%0.1%99.9%0.015L>S. Splice site changes.
rs7601176AG11.4%88.6%8.7%91.3%0.03No effect
rs1427294CT0.7%99.3%0.2%99.8%0.052No effect.

SNP: Single nucleotide polymorphism. Rs number  =  Reference Single Nucleotide Polymorphism number.

Predicted functional effect on protein synthesis.

*P-value for unadjusted allelic association between all TB patients and control subjects calculated using Fisher’s exact test. M  =  Methionine, T  =  Threonine, S =  serine, L =  leucine.

SNP: Single nucleotide polymorphism. Rs number  =  Reference Single Nucleotide Polymorphism number. Predicted functional effect on protein synthesis. *P-value for unadjusted allelic association between all TB patients and control subjects calculated using Fisher’s exact test. M  =  Methionine, T  =  Threonine, S =  serine, L =  leucine.

Bioinformatic analysis

SeattleSeq was used to annotate the data and this revealed that among the associated SNPs, effects were predicted for rs3948464 (L>S, Leucine>Serine) and rs1135791 (M>T; Methionine>Threonine). This was confirmed with in silico prediction of the functional impacts of associated polymorphisms using the MutationTaster algorithm (Table 4). Grantham scores, calculated by SeattleSeq, were available for rs1135791 (score 26) representing conservative chemical changes. Imputational analysis did not find any other SNPs in the regions near the associated SNPs to be more strongly linked to disease. Two of the SNPs associated with TB in the present study had been previously shown to have an association with TB in other populations, rs3948464 (with an effect shown in the opposite direction [18]) and rs1135791 [37], [38]. It remains unclear whether rs3948464 itself has a functional effect. An explanation for the difference between African and Asian populations is likely to relate to the different population prevalences of the SNPs. Among Africans the allele frequency of the T allele is 14%, while only 0.5% of Chinese have this variant. Therefore it is likely that the studies in China and Vietnam are not powered to detect associations between this SNP and disease. However, it is significant that the Vietnamese, Chinese and West African studies have found the same LD block to be associated with TB susceptibility. This suggests that while the identified markers may not directly have a biological effect, the SNPs in LD block 1 may be linked to a nearby disease-causing SNP. Together, these studies support a role for SP110 polymorphisms in the pathogenesis of TB. Forest plots showing results of meta-analyses of associated SNPs with other published studies are shown in the Figure S1, demonstrating heterogeneity between published studies, with a pooled analysis not reaching statistical significance. The predicted protein structure of SP110 is shown in Figure S3.

Discussion

Speckled Protein 110 kD (SP110) is a component of the multi-protein complex associated with the promyelocytic leukemia protein nuclear body that regulates transcription and influences aspects of the macrophage lifecycle, including cell differentiation, activation and apoptosis [14]. This genetic association study has demonstrated the association between six SNPs of SP110 and susceptibility to TB among the Vietnamese people, of which two remained associated with pulmonary disease (rs10208770, rs16826860 in the dominant model) and one with extra-pulmonary disease (rs10498244 in the recessive model). This is the first study to show an association between SP110 variants and both extrapulmonary and pulmonary disease, and the first published study of SP110 in the Vietnamese. In this study, the SNP rs10498244 was associated with more than a four times greater odds of extrapulmonary TB in patients than controls in the recessive model. A second SNP on the same LD block (rs10208770 came close to reaching statistical significance (p = 0.014) using a recessive model, likely explained by being in linkage disequilibrium with a causative SNP. Both SNPs were associated with pleural TB, which was the cause of most extrapulmonary disease. We also tested our subjects for three SNPs that have been shown to be associated with extrapulmonary TB in an Indian population [24], however among our population of 133 Vietnamese patients with extra-pulmonary TB we found no association for any of them. The difference between the two studies may be explained by differences in the site of extrapulmonary disease. Most patients with extrapulmonary TB in our study had pleural TB, while all patients in the Indian study had presumed lymph node disease. The finding of multiple SNPs that are associated with TB in this study is strongly supportive of a biological role for SP110 protein in the pathogenesis of the disease. This may either represent a single variant, or several variants. Given that several associated SNPs were in strong linkage disequilibrium with each other, this points towards a possible common causal SNP. Two of the SNPs most strongly associated with TB, rs10208770 and rs10498244 were in strong LD, with a D′ value of 99%. Furthermore, both SNPs were associated with pleural TB in a dominant model. Together, these findings suggest that a TB-susceptible DNA variant is present under this LD region, and that this may confer susceptibility to pleural and pulmonary TB. There have been few functional studies that elucidate the mechanism by which SP110 SNPs predispose to disease. This study has found two of the associated SNPs (rs11678451 and rs3948464) may have functional effects by testing the downstream effects of genetic changes using in silico analysis. Possible mechanisms for these effects include an alteration of transcript splice sites and alteration of protein sequence. These domains are conserved between some species and hence may play an important role in interferon-mediated cell replication and apoptosis [14]. There are three potentially important splice altering SNPs affecting the functional domain (NM_004509.3, NM_004510.3 and NM_080424.2), some of which maybe affected by our identified SNPs to alter the SP110 protein functional domains [16], [44]. Recently, another genetic variant in Sp110 (rs9061, T allele) was also found to be associated with TB, and when this variant was combined with an allele in MYBBP1A, which is also associated with TB in Han Chinese, the combined haplotype significantly increased the risk of TB [38]. MYBBP1A encodes a transcription factor required for haemopoiesis, and MYBBP1A also binds to RelA and represses NFκB, a critical signaling component in the pathway of macrophage activation [39]. SP110 binds to MYBBP1A in murine cells, and this interaction is required for SP110-induced apoptosis [38]. Therefore genetic variants in SP110 may influence macrophage signaling responses and apoptosis during M. tuberculosis infection, however the precise mechanisms by which SP110 SNPs rs11678451 and rs3948464 result in susceptibility to disease are yet to be established. In order to compare our results to other studies, we tested seven SNPs that had been previously associated with TB in one or more published studies. Rs1135791 has been significantly associated with TB in two published studies among the Han Chinese where the T>C allele was protective [37], [38]. Although this SNP was not statistically significant after adjustment in the Vietnamese, the LD block containing the SNP was significantly associated with the disease. Possible reasons for the lack of association with rs1135791 in the Vietnamese include (i) differences in genetic susceptibility between ethnic groups, such as different linkage disequilibrium patterns, and (ii) inadequate power in the present study. The Figures S1 and S2 summarize the findings of the published studies of the relationship between tuberculosis and SNPs that were tested in our study. False positive results arising from multiple testing are an important consideration for genetic association studies [40]. In order to account for this possibility, we calculated the ‘effective’ number of independent tests using an algorithm that assessed the LD between selected SNPs. The derived p-value threshold of 0.0078 was then applied to the results of the adjusted analysis. The overly conservative Bonferroni adjustment was not appropriate in this study, owing to the high degree of correlation (strong linkage disequilibrium) between the tested SNPs that increases the a priori probability of an association [31], [32], [41]. Further, there was a high degree of dependence between the results of recessive and dominant models [42]. As a result, we believe this approach to assessing statistical significance is appropriate. An important strength of this study is the clear phenotypic definitions for patients and controls. The microbiological confirmation of the pulmonary TB enabled clear classification of this group of patients, and chest radiograph enabled us to exclude active disease in controls and prevent misclassification of subjects. In addition, our method of selecting control subjects from within TB hospitals is a considerable strength, as health care workers in Vietnam have twice the likelihood of infection compared to other occupations. In a study by Lien et al, conducted among health care workers in the same setting as the present study, the prevalence of latent TB infection was shown to be 66.3% [43]. On this basis, it is likely that a high proportion of our control group had been infected with M. tuberculosis but not developed the disease, suggesting a degree of protection against progression to TB. Hence, this group is more likely to differ from patients in relation to the genetic and immunological factors responsible for disease progression. A limitation of this study was the different gender and age distribution between the control and patient groups. This difference is unlikely to have adversely affected our results, as most of the identified associations persisted in the multivariate analysis. In summary, this study has found six tag SNPs for SP110 associated with all forms of TB and one SNP associated with extra-pulmonary TB. Two of these SNPs were in close linkage disequilibrium, in a block that is largely conserved in human populations. The findings support a role for SP110 in both pulmonary TB and extra-pulmonary TB. Further work will be required to clarify the functional impact of these genetic variants in SP110 on the response of human macrophages to infection. Forest plot of the association between pulmonary TB and rs3948464 T>C in published studies. (TIFF) Click here for additional data file. Forest plot of the association between pulmonary TB and rs1135791 T>C in published studies. (TIFF) Click here for additional data file. Model of predicted protein structure of SP110. Hollow box represents the SP110 nuclear body protein (713 amino acids in length). Solid lines represent functional domains. Dashed line represents a putative acetyl lysine binding site. (TIFF) Click here for additional data file. Inclusion and exclusion criteria for tuberculosis patients. (DOCX) Click here for additional data file. Definitions of extra-pulmonary tuberculosis. (DOCX) Click here for additional data file. Extension primers for tested SNPs. (DOCX) Click here for additional data file. Allelic frequencies for all tuberculosis patients compared to control subjects. (DOCX) Click here for additional data file. Allele frequencies for patients with pulmonary TB compared to control subjects. (DOCX) Click here for additional data file.

Data availability statement

Genotyping data used in this study have been deposited in a publically accessible repository at the Centenary Institute, University of Sydney available at http://www.centenary.org.au/wp-content/uploads/2014/04/SP110-data-Vietnam-PLOS.xls.
  40 in total

1.  MutationTaster evaluates disease-causing potential of sequence alterations.

Authors:  Jana Marie Schwarz; Christian Rödelsperger; Markus Schuelke; Dominik Seelow
Journal:  Nat Methods       Date:  2010-08       Impact factor: 28.547

2.  Genetic association study suggests a role for SP110 variants in lymph node tuberculosis but not pulmonary tuberculosis in north Indians.

Authors:  Pankaj Jha; Ashima Jain; Komal Arora; Mridula Bose
Journal:  Hum Immunol       Date:  2011-04-20       Impact factor: 2.850

3.  Tuberculosis control and elimination 2010-50: cure, care, and social development.

Authors:  Knut Lönnroth; Kenneth G Castro; Jeremiah Muhwa Chakaya; Lakhbir Singh Chauhan; Katherine Floyd; Philippe Glaziou; Mario C Raviglione
Journal:  Lancet       Date:  2010-05-22       Impact factor: 79.321

Review 4.  Current findings, challenges and novel approaches in human genetic susceptibility to tuberculosis.

Authors:  Marlo Möller; Eileen G Hoal
Journal:  Tuberculosis (Edinb)       Date:  2010-03-04       Impact factor: 3.131

5.  Mouse model of necrotic tuberculosis granulomas develops hypoxic lesions.

Authors:  Jamie Harper; Ciaran Skerry; Stephanie L Davis; Rokeya Tasneen; Mariah Weir; Igor Kramnik; William R Bishai; Martin G Pomper; Eric L Nuermberger; Sanjay K Jain
Journal:  J Infect Dis       Date:  2011-12-23       Impact factor: 5.226

6.  Association of SP110 gene polymorphisms with susceptibility to tuberculosis in a Chinese population.

Authors:  Li Liang; Yan-lin Zhao; Jun Yue; Jian-fang Liu; Min Han; Hongxiu Wang; Heping Xiao
Journal:  Infect Genet Evol       Date:  2011-03-17       Impact factor: 3.342

Review 7.  Epidemiology of tuberculosis immunology.

Authors:  G J Fox; D Menzies
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

8.  Association of IFNGR2 gene polymorphisms with pulmonary tuberculosis among the Vietnamese.

Authors:  Minako Hijikata; Junko Shojima; Ikumi Matsushita; Katsushi Tokunaga; Jun Ohashi; Nguyen T L Hang; Toru Horie; Shinsaku Sakurada; Nguyen P Hoang; Pham H Thuong; Luu T Lien; Naoto Keicho
Journal:  Hum Genet       Date:  2011-11-06       Impact factor: 4.132

9.  Genome-wide association analyses identifies a susceptibility locus for tuberculosis on chromosome 18q11.2.

Authors:  Thorsten Thye; Fredrik O Vannberg; Rolf D Horstmann; Adrian V S Hill; Sunny H Wong; Ellis Owusu-Dabo; Ivy Osei; John Gyapong; Giorgio Sirugo; Fatou Sisay-Joof; Anthony Enimil; Margaret A Chinbuah; Sian Floyd; David K Warndorff; Lifted Sichali; Simon Malema; Amelia C Crampin; Bagrey Ngwira; Yik Y Teo; Kerrin Small; Kirk Rockett; Dominic Kwiatkowski; Paul E Fine; Philip C Hill; Melanie Newport; Christian Lienhardt; Richard A Adegbola; Tumani Corrah; Andreas Ziegler; Andrew P Morris; Christian G Meyer
Journal:  Nat Genet       Date:  2010-08-08       Impact factor: 38.330

10.  Prevalence and risk factors for tuberculosis infection among hospital workers in Hanoi, Viet Nam.

Authors:  Luu Thi Lien; Nguyen Thi Le Hang; Nobuyuki Kobayashi; Hideki Yanai; Emiko Toyota; Shinsaku Sakurada; Pham Huu Thuong; Vu Cao Cuong; Akiko Nanri; Tetsuya Mizoue; Ikumi Matsushita; Nobuyuki Harada; Kazue Higuchi; Le Anh Tuan; Naoto Keicho
Journal:  PLoS One       Date:  2009-08-27       Impact factor: 3.240

View more
  16 in total

1.  Tuberculosis-resistant transgenic cattle.

Authors:  Christopher K Tuggle; W Ray Waters
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-17       Impact factor: 11.205

2.  SP110b Controls Host Immunity and Susceptibility to Tuberculosis.

Authors:  Jia-Shiun Leu; Mei-Ling Chen; So-Yi Chang; Sung-Liang Yu; Chia-Wei Lin; Hsuan Wang; Wan-Chen Chen; Chin-Hao Chang; Jann-Yuan Wang; Li-Na Lee; Chong-Jen Yu; Igor Kramnik; Bo-Shiun Yan
Journal:  Am J Respir Crit Care Med       Date:  2017-02-01       Impact factor: 21.405

3.  Molecular epidemiology of M. tuberculosis in Ethiopia: A systematic review and meta-analysis.

Authors:  Daniel Mekonnen; Awoke Derbie; Asmamaw Chanie; Abebe Shumet; Fantahun Biadglegne; Yonas Kassahun; Kidist Bobosha; Adane Mihret; Liya Wassie; Abaineh Munshea; Endalkachew Nibret; Solomon Abebe Yimer; Tone Tønjum; Abraham Aseffa
Journal:  Tuberculosis (Edinb)       Date:  2019-08-07       Impact factor: 3.131

4.  Characterization of promoter of the tuberculosis-resistant gene intracellular pathogen resistance 1.

Authors:  Yongyan Wu; Fayang Liu; Yan Zhang; Yongsheng Wang; Zekun Guo; Yong Zhang
Journal:  Immunol Res       Date:  2016-02       Impact factor: 2.829

5.  Molecular characterization of Sp110 gene in pigs.

Authors:  Li-Zu Li; Qiu-Shi Wang; Li-Xin Han; Jin-Kui Wang; Si-Yu Shao; Liang Wang; Di Liu; Xiu-Qin Yang
Journal:  Mol Genet Genomics       Date:  2016-03-19       Impact factor: 3.291

6.  Whole genome sequencing identifies novel genetic mutations in patients with eczema herpeticum.

Authors:  Lianghua Bin; Claire Malley; Patricia Taylor; Meher Preethi Boorgula; Sameer Chavan; Michelle Daya; Malaika Mathias; Gautam Shankar; Nicholas Rafaels; Candelaria Vergara; Joseph Potee; Monica Campbell; Jon M Hanifin; Eric Simpson; Lynda C Schneider; Richard L Gallo; Tissa Hata; Amy S Paller; Anna De Benedetto; Lisa A Beck; Peck Y Ong; Emma Guttman-Yassky; Brittany Richers; David Baraghoshi; Ingo Ruczinski; Kathleen C Barnes; Donald Y M Leung; Rasika A Mathias
Journal:  Allergy       Date:  2021-03-15       Impact factor: 13.146

Review 7.  Certain Polymorphisms in SP110 Gene Confer Susceptibility to Tuberculosis: A Comprehensive Review and Updated Meta-Analysis.

Authors:  Shuai Zhang; Xue Bin Wang; Ya Di Han; Chen Wang; Ye Zhou; Fang Zheng
Journal:  Yonsei Med J       Date:  2017-01       Impact factor: 2.759

8.  Role of the transcriptional regulator SP140 in resistance to bacterial infections via repression of type I interferons.

Authors:  Daisy X Ji; Kristen C Witt; Dmitri I Kotov; Shally R Margolis; Alexander Louie; Victoria Chevée; Katherine J Chen; Moritz M Gaidt; Harmandeep S Dhaliwal; Angus Y Lee; Stephen L Nishimura; Dario S Zamboni; Igor Kramnik; Daniel A Portnoy; K Heran Darwin; Russell E Vance
Journal:  Elife       Date:  2021-06-21       Impact factor: 8.140

9.  The Arginine/Lysine-Rich Element within the DNA-Binding Domain Is Essential for Nuclear Localization and Function of the Intracellular Pathogen Resistance 1.

Authors:  Kezhen Yao; Yongyan Wu; Qi Chen; Zihan Zhang; Xin Chen; Yong Zhang
Journal:  PLoS One       Date:  2016-09-13       Impact factor: 3.240

10.  Functional domains of SP110 that modulate its transcriptional regulatory function and cellular translocation.

Authors:  Jia-Shiun Leu; So-Yi Chang; Chia-Yu Mu; Mei-Ling Chen; Bo-Shiun Yan
Journal:  J Biomed Sci       Date:  2018-04-11       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.